We are live on ! Find out more
PCM

Penserra Capital Management Portfolio holdings

AUM $8.52B
1-Year Est. Return 37.76%
This Fund
S&P 500
This Quarter Est. Return
+33.56%
1 Year Est. Return
+37.76%
3 Year Est. Return
+116.32%
5 Year Est. Return
+122.1%
10 Year Est. Return
+1,892.45%
AUM
$4.23B
AUM Growth
+$1.6B
Cap. Flow
+$897M
Cap. Flow %
21.18%
Top 10 Hldgs %
21.32%
Holding
1,176
New
232
Increased
605
Reduced
167
Closed
168

Top Buys

Rank Stock Value
1
BEKE icon
KE Holdings
BEKE
+$84.9M
2
LU icon
Lufax Holding
LU
+$59.6M
3
BABA icon
Alibaba
BABA
+$42.6M
4
JD icon
JD.com
JD
+$41.5M
5
GRPN icon
Groupon
GRPN
+$36.4M

Top Sells

Rank Stock Value
1
PTON icon
Peloton Interactive
PTON
+$25.2M
2
JMIA
Jumia Technologies
JMIA
+$21.7M
3
MTCH icon
Match Group
MTCH
+$20.5M
4
FVRR icon
Fiverr
FVRR
+$15.4M
5
SFIX
Stitch Fix
SFIX
+$10.7M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 34.91%
2 Technology 23.48%
3 Communication Services 13.86%
4 Financials 4.63%
5 Real Estate 4.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ENTA icon
851
Enanta Pharmaceuticals
ENTA
$400M
$19K ﹤0.01%
465
+295
+174% +$13K
ENVA icon
852
Enova International
ENVA
$6.29B
$19K ﹤0.01%
778
+774
+19,350% +$15.9K
HSIC icon
853
Henry Schein
HSIC
$9.82B
$19K ﹤0.01%
299
+61
+26% +$3.94K
LKQ icon
854
LKQ Corp
LKQ
$6.29B
$19K ﹤0.01%
551
-2,268
-80% -$77.6K
LNC icon
855
Lincoln National
LNC
$8.81B
$19K ﹤0.01%
385
+45
+13% +$1.91K
STRO icon
856
Sutro Biopharma
STRO
$421M
$19K ﹤0.01%
+90
New +$14.9K
WRB icon
857
W.R. Berkley
WRB
$26.6B
$19K ﹤0.01%
646
+187
+41% +$5.39K
RDUS
858
DELISTED
Radius Health, Inc.
RDUS
$19K ﹤0.01%
1,085
+689
+174% +$10.3K
HAPN
859
Happen Inc
HAPN
$2.24B
$18K ﹤0.01%
1,706
-1,691
-50% -$11.3K
PLRX icon
860
Pliant Therapeutics
PLRX
$65M
$18K ﹤0.01%
+825
New +$20.7K
QNCX icon
861
Quince Therapeutics
QNCX
$29.5M
$18K ﹤0.01%
+3
New +$26.6K
WU icon
862
Western Union
WU
$2.21B
$18K ﹤0.01%
865
-3,487
-80% -$75.7K
ICPT
863
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$18K ﹤0.01%
765
+483
+171% +$16K
Y
864
DELISTED
Alleghany Corp
Y
$18K ﹤0.01%
30
-4
-12% -$2.33K
FPRX
865
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$18K ﹤0.01%
+1,065
New +$13.3K
PRVL
866
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$18K ﹤0.01%
785
+493
+169% +$6.25K
ADAP
867
DELISTED
Adaptimmune Therapeutics
ADAP
$17K ﹤0.01%
+3,180
New +$17.3K
FSLR icon
868
First Solar
FSLR
$26.9B
$17K ﹤0.01%
179
-888
-83% -$77K
IRM icon
869
Iron Mountain
IRM
$36.1B
$17K ﹤0.01%
604
+128
+27% +$3.55K
OHI icon
870
Omega Healthcare
OHI
$14.7B
$17K ﹤0.01%
478
+104
+28% +$3.52K
PTGX icon
871
Protagonist Therapeutics
PTGX
$9.44B
$17K ﹤0.01%
880
+564
+178% +$12.1K
VER
872
DELISTED
VEREIT, Inc.
VER
$17K ﹤0.01%
454
+94
+26% +$3.34K
CMA
873
DELISTED
Comerica
CMA
$16K ﹤0.01%
290
+52
+22% +$2.54K
ESPR
874
DELISTED
Esperion Therapeutics
ESPR
$16K ﹤0.01%
640
+404
+171% +$12.1K
GOSS icon
875
Gossamer Bio
GOSS
$87M
$16K ﹤0.01%
1,755
+1,107
+171% +$10.9K
33 34
35
36 37

Similar funds

GRQ
Gardner Russo & Quinn Lancaster, Pennsylvania $8.5B AUM 9.79% 1-Year Est. Return
IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
NB
Norinchukin Bank Tokyo, Japan $8.57B AUM 20.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
ACM
Advisors Capital Management Ridgewood, New Jersey $8.58B AUM 23.43% 1-Year Est. Return
FT
Fiduciary Trust Boston, Massachusetts $8.46B AUM 21.38% 1-Year Est. Return
NW
NewEdge Wealth Pittsburgh, Pennsylvania $8.39B AUM 24.47% 1-Year Est. Return
AAF
Andra AP-fonden Goteborg, Sweden $8.39B AUM 21.19% 1-Year Est. Return

Penserra Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Penserra Capital Management held 1,176 positions worth $4.23B, up 61% from $2.63B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Penserra Capital Management deployed $897M of net new capital in Q4 2020, opening 232 new positions and adding to 605 existing holdings. Its largest new stake was KE Holdings: 1,278,021 shares worth $78.6M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Peloton Interactive, an estimated $25.2M trimmed.

  • Penserra Capital Management's largest Q4 2020 buy was KE Holdings: 1,278,021 shares worth $78.6M.
  • Penserra Capital Management added most to Alibaba in Q4 2020, an estimated $42.6M increase.
  • Penserra Capital Management's biggest Q4 2020 reduction was Peloton Interactive, cutting an estimated $25.2M.
  • Penserra Capital Management fully exited Palomar in Q4 2020, selling an estimated $6.65M.
  • Penserra Capital Management's ten largest holdings make up 21% of its $4.23B portfolio in Q4 2020.
  • Penserra Capital Management opened 232 new positions and closed 168 in Q4 2020.
  • Penserra Capital Management's portfolio value rose 61% quarter-over-quarter to $4.23B.

Based on Penserra Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.